πŸ‡ΊπŸ‡Έ FDA
Patent

US 10815463

Messenger UNA molecules and uses thereof

granted A61KA61K39/00A61K48/00

Quick answer

US patent 10815463 (Messenger UNA molecules and uses thereof) held by ARCTURUS THERAPEUTICS, INC. expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCTURUS THERAPEUTICS, INC.
Grant date
Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K39/00, A61K48/00, A61P, A61P1/16